Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs. 1995

E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
Division of Veterinary Microbiology, Kyoto Biken Laboratories, Japan.

Cell-free-antigens prepared from a concentrated culture supernatant of Actinobacillus pleuropneumoniae (A. pleuropneumoniae) serotypes 1, 2 and 5 were mixed and emulsified with oil adjuvant. The combined vaccine of these 3 serotypes of A. pleuropneumoniae was tested for its ability to confer protection. Pigs immunized with the combined vaccine survived and showed no clinical signs against an intratracheal challenge with A. pleuropneumoniae. In contrast, control pigs inoculated with concentrated culture media emulsified with oil adjuvant developed typical symptoms of pleuropneumonia after challenge inoculation.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D002474 Cell-Free System A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166) Cellfree System,Cell Free System,Cell-Free Systems,Cellfree Systems,System, Cell-Free,System, Cellfree,Systems, Cell-Free,Systems, Cellfree
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000189 Actinobacillus Infections Infections with bacteria of the genus ACTINOBACILLUS. Infections, Actinobacillus,Actinobacillus Infection,Infection, Actinobacillus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings

Related Publications

E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
October 1996, Veterinary microbiology,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
August 1993, The Journal of veterinary medical science,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
June 1999, The Journal of veterinary medical science,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
April 1994, The Canadian veterinary journal = La revue veterinaire canadienne,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
July 2020, Journal of microbiology and biotechnology,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
May 2010, The Journal of veterinary medical science,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
January 1985, Nordisk veterinaermedicin,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
August 1998, The Veterinary record,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
July 1998, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
E Oishi, and T Kitajima, and Y Koyama, and T Ohgitani, and S Katayama, and T Okabe
November 2010, Journal of bacteriology,
Copied contents to your clipboard!